FDA revises letter of authorization for the emergency use authorization for Paxlovid
EUA-labeled Paxlovid is no longer authorized for emergency use, regardless of the labeled or extended expiration date. For both NDA-approved and EUA-authorized uses, only NDA-labeled Paxlovid may be dispensed. Today’s revision to the Paxlovid EUA completes FDA’s transition to FDA-approved Paxlovid from EUA-labeled Paxlovid. All EUA-labeled Paxlovid, including expired EUA-labeled Paxlovid, remaining in U.S. distribution […]
COVID-19 Vaccines for 2024-2025 (FDA)
Which updated COVID-19 vaccines are available? The FDA has approved and authorized for emergency use updated COVID-19 vaccines (2024-2025 formula) to provide better protection against COVID-19 caused by circulating variants. Specifically, FDA has authorized the following for emergency use:Moderna COVID-19 Vaccine (2024-2025 Formula) for individuals 6 months through 11 years of age Novavax COVID-19 Vaccine, […]
COVID-19 Epidemiological update
Epidemiological update on COVID-19. Number of cases and deaths globally, regionally and nationally, with key data and trends. Epidemiological report of the (WHO) Read More Epidemiology of COVID-19 in Mexico (CONACYT) Read More Weekly report on covid-19, influenza and other respiratory viruses, 2024 (Secretariat of Health) Read More
Impact of COVID-19 on Healthy Life Expectancy of Older Adults in the Region of the Americas
Washington DC, 21 August 2024- The Region of the Americas has experienced a significant decline in the healthy life expectancy (HALE) of older adults at age 60 due to the COVID-19 pandemic. New data from the WHO Global Health Observatory reveals that the HALE at 60 years old was reduced from 16.61 years in 2019 […]
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect
August 22, 2024.- The U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating […]
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect
August 30, 2024.- The U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of […]
What we have learned about SARS-CoV-2 in Latin America and the Caribbean
On February 26, 2020, Brazil reported the first case of COVID-19, setting the beginning of the pandemic in Latin America and the Caribbean. Since its first appearance on December 30, 2019, in Wuhan, China, the SARS-CoV-2 virus left a devastating trail around the globe, with 774 million cases and 7 million deaths recorded to date. […]
Urgent call to achieve an agreement on future pandemics
Only a strong global pact against pandemics can protect the future generations from suffering again a similar unpleasant experience such as the COVID-19 crisis On March 20 of the current year, 23 former national Presidents, 22 former Prime Ministers, a former UN General Secretary and 3 Nobel Laureates is being made today to press for […]
COVID-19 vaccines available for sale in Mexico
COFEPRIS released an official communication that provided the sanitary certificate to Pfizer y Moderna Covid-19 vaccines. A multidisciplinary federal staff team determined that the Pfizer & Moderna biologicals met the quality, safety and efficacy requirements complying with the total commitment to transparency, under the crystal box principle, the Federal Commission for the Protection Against Health […]
